Access to Prescription Digital Therapeutics Act of 2023

Rate

AI Summary: The "Access to Prescription Digital Therapeutics Act of 2023" is a federal bill aimed at expanding access to prescription digital therapeutics (PDTs) for patients. The main provisions of the bill include establishing a framework for the approval and regulation of PDTs by the Food and Drug Administration (FDA), ensuring that these digital treatments meet safety and efficacy standards similar to traditional medications.

This bill proposes to create a new category within the FDA's regulatory framework specifically for PDTs, allowing healthcare providers to prescribe these digital therapies as part of patient treatment plans. The goal is to enhance patient care by integrating innovative digital solutions into traditional healthcare practices.

If passed, this bill could lead to significant advancements in the use of digital technologies for treating various medical conditions, providing patients with more options for personalized and effective care.

Latest Action: Introduced in House

Comments Contributions Actions (3) Sponsors (1) Cosponsors (26) Text Versions (1) Roll Calls (0) Amendments (0) View All

Contributions (0)

Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.

Actions (3):

2023-03-08 : Introduced in House
2023-03-08 : Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2023-03-17 : Referred to the Subcommittee on Health.